The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Cellular Fatty Acid Metabolism and Cancer
Open accessAbstract
Cancer cells often have characteristic changes in metabolism. Cellular proliferation, a common feature of all cancers, requires fatty acids for synthesis of membranes and signaling molecules. Here, we provide a view of cancer cell metabolism from a lipid perspective, and we summarize evidence that limiting fatty acid availability can control cancer cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, expression of ACLY, a key enzyme in the shift from the TCA cycle to lipid formation that has been shown to cause lipid droplet accumulation42, is significantly higher in LDAM than in microglia without lipid droplets.”
From Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredIn the citing paper
“Fatty acid synthesis is an anabolic process that uses cytosolic citrate to produce acetyl-CoA73.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [73]
In the citing paper
“Next, mitochondrial citrate is transported across the inner mitochondrial membrane via a citrate carrier (CIC or SLC25A1) to support fatty acid synthesis for tumor progression in hypoxia73 (Fig. 4).”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [73]
In the citing paper
“PHD3 is suppressed in cancers that rely on FAO, such as AML and prostate cancer, and elevated in cancers that rely on FAS such as breast and non-small-lung-cell cancer.55–57”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“A better understanding of these metabolic changes has prompted new approaches toward cancer therapy (reviewed in Hsu and Sabatini, 2008; Schulze and Harris, 2012).”
BackgroundATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,000
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Xu, D., Yin, S., & Shu, Y. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00627-5 · Cited by 36
Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
Roy, D., Mondal, S., Wang, C., He, X., Khurana, A., Giri, S., Hoffmann, R. G., Jung, D., Kim, S. H., Chini, E. N., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-13 · Cited by 37
To, M., Peterson, C. W. H., Roberts, M. A., Counihan, J. L., Wu, T., Forster, M. S., Nomura, D. K., & Olzmann, J. A. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-07-0483 · Cited by 34
microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism
Ru, P., & Guo, D. (2017) · RNA & DISEASE · doi:10.14800/rd.1525 · Cited by 34
STAT3 Regulation of Citrate Synthase Is Essential during the Initiation of Lymphocyte Cell Growth
MacPherson, S., Horkoff, M. J., Gravel, C., Hoffmann, T., Zuber, J. A., & Lum, J. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.012 · Cited by 33
Muranaka, H., Hayashi, A., Minami, K., Kitajima, S., Kohno, S., Nishimoto, Y., Nagatani, N., Suzuki, M., Kulathunga, L. A. N., Sasaki, N., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.51 · Cited by 34
Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugs
Jamieson, L. E., Wetherill, C., Faulds, K., & Graham, D. (2018) · Chemical Science · doi:10.1039/c8sc02312c · Cited by 34
Profiling the Metabolism of Human Cells by Deep 13C Labeling
Grankvist, N., Watrous, J. D., Lagerborg, K. A., Lyutvinskiy, Y., Jain, M., & Nilsson, R. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.09.004 · Cited by 32
MicroRNAs and signaling networks involved in epithelial–mesenchymal transition
Shenas, M. H. M., Eghbal‐Fard, S., Mehrisofiani, V., Yazdani, N. A., Farzam, O. R., Marofi, F., & Yousefi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27489 · Cited by 34
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin
Pes, G. M., Errigo, A., Soro, S., Longo, N. P., & Dore, M. P. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1616815 · Cited by 34
Han, Y., Lee, J. H., & Lee, S. H. (2019) · Marine Drugs · doi:10.3390/md17090518 · Cited by 35
C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake
Wang, D., Cheng, X., Li, Y., Guo, M., Zhao, W., Qiu, J., Zheng, Y. F., Meng, M., Ping, X., Chen, X., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1015-z · Cited by 34
Wang, M.-D., Wang, N.-Y., Zhang, H., Sun, L., Xu, Q., Liang, L., Li, C., Huang, D., Zhu, H., & Yang, T. (2021) · Oncogenesis · doi:10.1038/s41389-021-00364-5 · Cited by 35
Targeting autophagy and lipid metabolism in cancer stem cells
Chakravarti, B., Siddiqui, J. A., Sinha, R. A., & Raza, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115550 · Cited by 38
Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
Wang, B., Zhang, Z., Liu, W., & Tan, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114180 · Cited by 38
Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation
Huang, Y., Wang, F., Lin, X., Li, Q., Lu, Y., Zhang, J., Shen, X. H., Tan, J., Qin, Z., Chen, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221653120 · Cited by 33
Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application
Huang, X., Liu, B., & Shen, S. (2025) · Cancers · doi:10.3390/cancers17040650 · Cited by 34
Extracellular vesicles in metabolic perspective: mechanism and targeted therapy
Sheng, Q., Wu, Z., Li, W., Wang, L., Xu, H., Wang, W., Yan, Z., Ge, G., Xu, Y., & Geng, D. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03763-7 · Cited by 36
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 36
Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival
Huang, J., Weinstein, S. J., Moore, S. C., Derkach, A., Hua, X., Mondul, A. M., Sampson, J. N., & Albanes, D. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly128 · Cited by 33
Robichaud, P.-P., Munganyiki, J. É., Boilard, É., & Surette, M. E. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m090050 · Cited by 33
Škulj, S., & Vazdar, M. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp01204d · Cited by 33
Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis
Hsieh, Y.-T., Chen, Y., Lin, S., Chang, K., & Li, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163960 · Cited by 33
Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy
Mendes, C., Lopes‐Coelho, F., Ramos, C., Martins, F., Santos, I. P., Rodrigues, A., SILVA, F. A. B. N. D., André, S., & Serpa, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-50531-3 · Cited by 35
Zhang, Z., Zhang, S., Yang, J., Yi, P., Xu, P., Yi, M., & Peng, W. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115100 · Cited by 33
Bai, D., Wu, Y., Deol, P., Nobumori, Y., Zhou, Q., Sladek, F. M., & Liu, X. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.007 · Cited by 33
Paolino, G., Huber, V., Camerini, S., Casella, M., Macone, A., Bertuccini, L., Iosi, F., Moliterni, E., Cecchetti, S., Ruspantini, I., et al. (2021) · Cancers · doi:10.3390/cancers13164157 · Cited by 33
Alternative Splicing in Cancer and Immune Cells
Bernard, A., Boidot, R., & Végran, F. (2022) · Cancers · doi:10.3390/cancers14071726 · Cited by 33
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells
Casella, C., Miller, D. H., Lynch, K. D., & Brodsky, A. S. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.08.015 · Cited by 33
Turcios, L. M., Vilchez, V., Acosta, L. F., Pratheeshkumar, P., Butterfield, D. A., Mitov, M. I., Martí, F., & Gedaly, R. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.146 · Cited by 33
Kononenko, V., Erman, A., Petan, T., Križaj, I., Kralj, S., Makovec, D., & Drobne, D. (2017) · Nanotoxicology · doi:10.1080/17435390.2017.1309704 · Cited by 33
The Ubiquitin–Proteasome System in Tumor Metabolism
Wang, J., Xiang, Y., Fan, M., Fang, S., & Hua, Q. (2023) · Cancers · doi:10.3390/cancers15082385 · Cited by 32
Zhang, S., Zhang, Z., Liu, X., Deng, Y., Zheng, J., Deng, J., Wang, Y., Guo, B., Li, F., Chen, X., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0781 · Cited by 32
García, M. R., Foretz, M., Viollet, B., Prieto, A., Fraga, M., García‐Caballero, T., Costoya, J. A., & Señarís, R. M. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.014 · Cited by 32
Xu, H., Luo, J., Tian, H., Li, J., Zhang, X., Chen, Z., Li, M., & Loor, J. J. (2018) · Journal of Animal Science · doi:10.1093/jas/sky069 · Cited by 33
AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
Rae, C. J., & Mairs, R. J. (2019) · Oncotarget · doi:10.18632/oncotarget.26598 · Cited by 31
Göttgens, E., van den Heuvel, C. N. A. M., de Jong, M. C., Kaanders, J. H. A. M., Leenders, W. P. J., Ansems, M., Bussink, J., & Span, P. N. (2019) · Cancers · doi:10.3390/cancers11121971 · Cited by 32
Khan, A., Aljarbou, A. N., Aldebasi, Y. H., Allemeilam, K. S., Alsahly, M. A., Khan, S., Alruwetei, A. M., & Khan, M. A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s256022 · Cited by 32
Nilsson, K. D., Neittaanmäki, N., Zaar, O., Angerer, T. B., Paoli, J., & Fletcher, J. S. (2020) · Biointerphases · doi:10.1116/6.0000340 · Cited by 32
GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling
Fröhlich, J., Mazza, T., Sobolewski, C., Foti, M., & Vinciguerra, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158920 · Cited by 33
Fantacuzzi, M., Amoroso, R., & Ammazzalorso, A. (2022) · Biology · doi:10.3390/biology11010114 · Cited by 33
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 34
Liao, W., Du, J., Wang, Z., Feng, Q., Liao, M., Liu, H., Yuan, K., & Zeng, Y. (2022) · International Journal of Cancer · doi:10.1002/ijc.34040 · Cited by 31
Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma
Garcia, K. A., Costa, M. L., Lacunza, E., Martinez, M. E., Córsico, B., & Scaglia, N. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120621 · Cited by 32
Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy
Westheim, A. J. F., Stoffels, L. M., Dubois, L. J., van Bergenhenegouwen, J., van Helvoort, A., LANGEN, R. C. J., Shiri‐Sverdlov, R., & Theys, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.868436 · Cited by 37
Xu, L., Ziegelbauer, J. M., Wang, R., Wu, W. W., Shen, R., Juhl, H. H., Zhang, Y., & Rosenberg, A. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0737 · Cited by 32
Halama, A., Guerrouahen, B. S., Pasquier, J., Satheesh, N. J., Suhre, K., & Rafii, A. (2017) · Scientific Reports · doi:10.1038/srep39999 · Cited by 32
Li, L., Hua, L., Fan, H., He, Y., Xu, W., Zhang, L., Yang, J., Deng, F., & Zeng, F. (2019) · Journal of Cancer · doi:10.7150/jca.31254 · Cited by 32
Peng, Y., Xu, C., Wen, J., Zhang, Y., Wang, M., Liu, X., Zhao, K., Wang, Z., Liu, Y., & Zhang, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704038 · Cited by 30
Ding, X., Qin, J., Huang, F., Feng, F., & Luo, L. (2023) · Inflammation Research · doi:10.1007/s00011-023-01732-0 · Cited by 31
Mallick, R., Bhowmik, P., & Duttaroy, A. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115591 · Cited by 35
Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer
Liu, M., Zhang, Z., Chen, Y., Feng, T., Zhou, Q., & Tian, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1292011 · Cited by 34
Lao, M., Zhang, X., Li, Z., Sun, K., Yang, H., Wang, S., He, L., Chen, Y., Zhang, H., Shi, J., et al. (2025) · 癌症:英文版 · doi:10.1002/cac2.70038 · Cited by 31
Bottom up design of nanoparticles for anti-cancer diapeutics: “put the drug in the cancer’s food”
Needham, D., Arslanagic, A., Glud, K., Hervella, P., Karimi, L., Høeilund-Carlsen, P.-F., Kinoshita, K., Mollenhauer, J., Parra‐Ortiz, E., Utoft, A., et al. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1238092 · Cited by 31
Poolsri, W., Phokrai, P., Suwankulanan, S., Phakdeeto, N., Phunsomboon, P., Pekthong, D., Richert, L., Pongcharoen, S., & Srisawang, P. (2018) · BioMed Research International · doi:10.1155/2018/3683026 · Cited by 31
Nishi, K., Suzuki, M., YAMAMOTO, N., Matsumoto, A., Iwase, Y., Yamasaki, K., Otagiri, M., & Yumita, N. (2018) · Anticancer Research · doi:10.21873/anticanres.13036 · Cited by 33
Dinarvand, N., Khanahmad, H., Hakimian, S. M., Sheikhi, A., Rashidi, B., Bakhtiari, H., & Pourfarzam, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29523 · Cited by 31
Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients
Noreldeen, H. A. A., Du, L., Li, W., Liu, X., Wang, Y., & Xu, G. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113220 · Cited by 31
Li, L., Peng, Z., Hu, Q., Xu, L., Zou, X. G., Yu, Y., Huang, D., & Yi, P. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6195050 · Cited by 31
Bhattacharjee, K., Nath, M., & Choudhury, Y. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100798 · Cited by 34
Exploiting S-nitrosylation for cancer therapy: facts and perspectives
Rizza, S., & Filomeni, G. (2020) · Biochemical Journal · doi:10.1042/bcj20200064 · Cited by 31
The central role of mitochondria in the relationship between dietary lipids and cancer progression
Varela‐López, A., Ramírez, L. V., Giampieri, F., Navarro‐Hortal, M. D., Forbes-Hernández, T. Y., Battino, M. A., & Quiles, J. L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.001 · Cited by 31
Cortini, M., Armirotti, A., Columbaro, M., Longo, D. L., Pompo, G. D., Cannas, E., Maresca, A., Errani, C., Longhi, A., Righi, A., et al. (2021) · Cancers · doi:10.3390/cancers13020311 · Cited by 32
Zhu, Y., Yang, D., Duan, X., Zhang, Y., Chen, D., Gong, Z., & Liu, C. (2021) · Environmental Research · doi:10.1016/j.envres.2021.110962 · Cited by 31
A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism
Sheraj, I., Güray, T., & Banerjee, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93003-3 · Cited by 31
Iftikhar, R., Penrose, H. M., King, A. N., Samudre, J. S., Collins, M. E., Hartono, A. B., Lee, S. B., Lau, F. H., Baddoo, M., Flemington, E. F., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00373-4 · Cited by 32
Feng, Y., Wang, R., Li, C., Cai, X., Huo, Z., Liu, Z., Ge, F., Huang, C., Lu, Y., Zhong, R., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-34 · Cited by 31
The Modulatory Effects of Fatty Acids on Cancer Progression
Westheim, A. J. F., Stoffels, L. M., Dubois, L. J., van Bergenhenegouwen, J., van Helvoort, A., LANGEN, R. C. J., Shiri‐Sverdlov, R., & Theys, J. (2023) · Biomedicines · doi:10.3390/biomedicines11020280 · Cited by 31
mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment
Masui, K., Cavenee, W. K., & Mischel, P. S. (2015) · Brain Pathology · doi:10.1111/bpa.12307 · Cited by 31
Wen, S., Luo, Y., Wu, W., Zhang, T.-T., Yang, Y., Ji, Q., Wu, Y., Shi, R., Ma, B., Xu, M., et al. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab145 · Cited by 30
Zhang, G., Yu, X., Guo, H., Sun, J., Liu, Z., Zhu, J., Liu, T., Dong, L., Shen, X., & Yin, J. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2156 · Cited by 30
Qiao, L., Dou, X., Song, X., Chang, J., Zeng, X., Zhu, L., Yi, H., & Xu, C. (2023) · Animal nutrition · doi:10.1016/j.aninu.2023.08.003 · Cited by 31
Intratumoral metabolic heterogeneity of colorectal cancer
Hirose, Y., & Taniguchi, K. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2021 · Cited by 31
Metabolic Plasticity of Stem Cells and Macrophages in Cancer
Krstić, J., Trivanović, D. I., Jauković, A., Santibanez, J. F., & Bugarski, D. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00939 · Cited by 31
Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?
Mentoor, I., Engelbrecht, A., & Nell, T. A. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.11.009 · Cited by 28
Clinical significance and function of RDH16 as a tumor‐suppressing gene in hepatocellular carcinoma
Zhu, Y., Li, J., Wu, R., Yu, Y., Li, X., Li, Z., Zhang, H., Feng, G., Deng, R., & Zhu, X. (2019) · Hepatology Research · doi:10.1111/hepr.13432 · Cited by 30
van der Mijn, J. C., Fu, L., Khani, F., Zhang, T., Molina, A. M., Barbieri, C. E., Chen, Q., Gross, S. S., Gudas, L. J., & Nanus, D. M. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.10.015 · Cited by 31
Fan, Y., Noreldeen, H. A. A., You, L., Liu, X., Pan, X., Hou, Z., Li, Q., Li, X., & Xu, G. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113520 · Cited by 30
Metabolic markers for diagnosis and risk-prediction of multiple myeloma
Fei, F., Ma, T., Zhou, X., Zheng, M., Cao, B., & Li, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118852 · Cited by 30
Exogenous Fatty Acids Modulate ER Lipid Composition and Metabolism in Breast Cancer Cells
Rizzo, A. M., Colombo, I., Montorfano, G., Zava, S., & Corsetto, P. A. (2021) · Cells · doi:10.3390/cells10010175 · Cited by 28
Wu, Y., Zhou, Y., Gao, H., Wang, Y., Cheng, Q., Jian, S., Ding, Q., Gu, W., Yao, Y., Ma, J., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9979707 · Cited by 30
Fingerprinting Breast Cancer vs. Normal Mammary Cells by Mass Spectrometric Analysis of Volatiles
He, J., Sinues, P., Hollmén, M., Li, X., Detmar, M. J., & Zenobi, R. (2014) · Scientific Reports · doi:10.1038/srep05196 · Cited by 30
PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro
Kan, C. F. K., Singh, A. B., Dong, B., Shende, V. R., & Liu, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.008 · Cited by 32
Yoshida, T., Yokobori, T., Saito, H., Kuriyama, K., Kumakura, Y., Honjo, H., Hara, K., Sakai, M., Miyazaki, T., Obinata, H., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08711-3 · Cited by 30
The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers
Tondo-Steele, K., & McLean, K. (2022) · Cancers · doi:10.3390/cancers14194696 · Cited by 29
Sun, Y., Guo, W., Guo, Y., Lin, Z., Wang, D., Guo, Q., & Zhou, Y. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113450 · Cited by 29
Host cells reprogram lipid droplet synthesis through YY1 to resist PRRSV infection
Zheng, Z., Ling, X., Li, Y., Qiao, S., Zhang, S., Wu, J., Ma, Z., Li, M., Guo, X., Li, Z., et al. (2024) · mBio · doi:10.1128/mbio.01549-24 · Cited by 29
Vitamin D, intermediary metabolism and prostate cancer tumor progression
Wang, W.-L. W., & Tenniswood, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00183 · Cited by 30
Mehdizadeh, A., Bonyadi, M. J., Darabi, M., Rahbarghazi, R., Montazersaheb, S., Velaei, K., Shaaker, M., & Somi, M. H. (2017) · Bioimpacts · doi:10.15171/bi.2017.05 · Cited by 29
Fatty acid oxidation alleviates the energy deficiency caused by the loss of MPC1 in MPC1+/− mice
Zou, S., Lang, T., Zhang, B., Huang, K., Gong, L., Luo, H., Xu, W., & He, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.134 · Cited by 28
Ma, J., Feng, J.-F., & Zhou, X. D. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104466 · Cited by 28
Impact of curcumin on fatty acid metabolism
Nosrati‐Oskouie, M., Aghili‐Moghaddam, N. S., Sathyapalan, T., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7105 · Cited by 29
Zhang, C., Zhu, N., Wang, Y., Liu, L., Zhao, T., Wu, H.-T., Liao, D., & Li, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.658092 · Cited by 29
Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
Liu, B., Su, Q., Ma, J., Chen, C. Y., Wang, L., Che, F., & Heng, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657002 · Cited by 29
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
Rios, R. S., Zheng, K. I., & Zheng, M.-H. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001888 · Cited by 29
Sun, H., Wang, F., Huang, Y., Wang, J., Zhang, L., Shen, Y., Lin, C., & Guo, P. (2022) · Journal of Cancer · doi:10.7150/jca.52778 · Cited by 29
A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes
Rumora, A. E., Kim, B., & Feldman, E. L. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0155 · Cited by 32
Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells
Zhan, Y., Qiao, W., Yi, B., Yang, X., Li, M., Sun, L., Ji, L., Su, P., Wang, X., Zhang, F., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02445-0 · Cited by 30
Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasion
Velez, B. C., Petrella, C., DiSalvo, K. H., Cheng, K., Kravtsov, R. L., Krasniqi, D., & Krucher, N. A. (2022) · Oncology Reports · doi:10.3892/or.2022.8469 · Cited by 31
Metadata
- Authors
- Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V.
- Affiliations
- University of California, San Francisco (US)
- Cancer Research UK (GB)
- University of Graz (AT)
- Yale University (US)
- Corresponding author
- Farese, Robert V.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 18
- Issue
- 2
- Pages
- 153-161
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3742569
- OpenAlex
- W1980568044
- Cited by
- 2,123
- References
- 82
- Citations by year
- 2026: 118 · 2025: 221 · 2024: 228 · 2023: 221 · 2022: 266 · 2021: 204 · 2020: 193 · 2019: 177 · 2018: 139 · 2017: 122 · 2016: 115 · 2015: 72 · 2014: 41 · 2013: 1
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM099844, R01GM097194)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056084, P30DK063720, P30DK026743)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- fatty acid metabolism, cancer metabolism, lipid metabolism, tumor cell proliferation, fatty acid availability, membrane lipid synthesis
- MeSH terms
- Energy Metabolism, Fatty Acids, Humans, Neoplasms, Cell Proliferation, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review